跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-CITALOPRAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-CITALOPRAM
Authorized
STANDARD
BIO-CITALOPRAM
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8bf08942ca4ccb22
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
8bf08942ca4ccb22
Drug Approval Canada Name
BIO-CITALOPRAM
Product Name
BIO-CITALOPRAM
Status
Dormant
Status Date
2020-09-29
Original Market Date
2016-07-29
Din
02448475
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB04 CITALOPRAM
Atc Name
n 06 ab 04
Aig Number
0136243003
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
CITALOPRAM (CITALOPRAM HYDROBROMIDE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8bf08942ca4ccb22
Type
Standard
Back to Health Canada Approvals